It’s unclear what he has been up to during his entire 20 years on the lam. However, police had identified more than a dozen aliases he had been using. His police profile described him as a “master yachtsman, a world traveler, and internationally connected,” and noted that he had been featured on the television show America’s Most Wanted.
Biotech career
Stat reported that in 2017, Richard Graydon self-published a book titled The Genetic Risks of Cancer: The Effects of DNA, Genomics and Inheritance on Aging and Survival.” The book described Graydon as an oncologist who had served as a chief medical officer in the biotech and drug development industry. It had no reviews on Amazon.
In October 2022, Atossa Therapeutics, a Seattle-based biotech, announced it had hired Richard Graydon as its interim chief medical officer.
“We are privileged to welcome Richard to Atossa, where his deep experience in CAR-T cell therapy fits well with our current strategic direction as we explore our opportunities in cell therapy,” Steven Quay, Atossa’s CEO, said in a statement at the time.
